Restricted and non-essential redundancy of RNAi and piRNA pathways in mouse oocytes

PLoS Genet. 2019 Dec 20;15(12):e1008261. doi: 10.1371/journal.pgen.1008261. eCollection 2019 Dec.

Abstract

Germline genome defense evolves to recognize and suppress retrotransposons. One of defensive mechanisms is the PIWI-associated RNA (piRNA) pathway, which employs small RNAs for sequence-specific repression. The loss of the piRNA pathway in mice causes male sterility while females remain fertile. Unlike spermatogenic cells, mouse oocytes posses also RNA interference (RNAi), another small RNA pathway capable of retrotransposon suppression. To examine whether RNAi compensates the loss of the piRNA pathway, we produced a new RNAi pathway mutant DicerSOM and crossed it with a catalytically-dead mutant of Mili, an essential piRNA gene. Normal follicular and oocyte development in double mutants showed that RNAi does not suppress a strong ovarian piRNA knock-out phenotype. However, we observed redundant and non-redundant targeting of specific retrotransposon families illustrating stochasticity of recognition and targeting of invading retrotransposons. Intracisternal A Particle retrotransposon was mainly targeted by the piRNA pathway, MaLR and RLTR10 retrotransposons were targeted mainly by RNAi. Double mutants showed accumulations of LINE-1 retrotransposon transcripts. However, we did not find strong evidence for transcriptional activation and mobilization of retrotransposition competent LINE-1 elements suggesting that while both defense pathways are simultaneously expendable for ovarian oocyte development, yet another transcriptional silencing mechanism prevents mobilization of LINE-1 elements.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Argonaute Proteins / genetics
  • DEAD-box RNA Helicases / genetics
  • Female
  • Mice
  • Mutation
  • Oocytes / chemistry
  • Oocytes / growth & development*
  • RNA Interference*
  • RNA, Small Interfering / genetics*
  • Retroelements*
  • Ribonuclease III / genetics
  • Signal Transduction

Substances

  • Argonaute Proteins
  • Piwil2 protein, mouse
  • RNA, Small Interfering
  • Retroelements
  • Dicer1 protein, mouse
  • Ribonuclease III
  • DEAD-box RNA Helicases

Grants and funding

This work was funded from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 647403, D-FENS). Additional support was provided by the Ministry of Education, Youth, and Sports (MEYS) project NPU1 LO1419 (Biomodels for health). Financial support of E.T. and F.H. was in part provided by the Charles University through a PhD student fellowship; this work will be in part used to fulfill requirements for a PhD degree and hence can be considered “school work”. FH and ZJM were supported by the European Structural and Investment Funds grant for the Croatian National Centre of Research Excellence in Personalized Healthcare (contract #KK.01.1.1.01.0010), Croatian National Centre of Research Excellence for Data Science and Advanced Cooperative Systems (contract #KK.01.1.1.01.0009) and Croatian Science Foundation (grant IP-2014-09-6400). Production and histology analysis of the DicerSOM mice was supported by RVO 68378050 by Academy of Sciences of the Czech Republic and by LM2015040 (Czech Centre for Phenogenomics), CZ.1.05/2.1.00/19.0395 (Higher quality and capacity for transgenic models), CZ.1.05/1.1.00/02.0109 (BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University). Microscopy was done at the Light Microscopy Core Facility, IMG CAS, Prague, Czech Republic supported by LM2015062 (Czech-Bioimaging). Additional computational resources were provided by CESNET LM2015042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.